Isotretinoin as a diagnostic tool for localization of thyroid tissue in a thyroid cancer patient: A case report

Thyroid

Volumn 17, Issue 9, 2007, Pages 893-896

  Coelho, Sabrina Mendes ^a   De Almeida, Ronald Freire ^b   Corbo, Rossana ^a   Breitenbach, Marisa M D ^c   Carvalho, Denise P ^a   Vaisman, Mário ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

^c STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; ISOTRETINOIN; LEVOTHYROXINE; RADIOACTIVE IODINE; RECOMBINANT THYROTROPIN; THYROGLOBULIN;

ADULT; ARTICLE; CANCER RELAPSE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DRY SKIN; ECHOGRAPHY; HUMAN; HUMAN TISSUE; HYPERTRIGLYCERIDEMIA; HYPOTHYROIDISM; IMAGE ANALYSIS; MALE; MUCOSAL DRYNESS; PRIORITY JOURNAL; THYROID CANCER; TUMOR LOCALIZATION; WHOLE BODY SCINTISCANNING;

CARCINOMA, PAPILLARY; FEMALE; HUMANS; ISOTRETINOIN; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; THYROGLOBULIN; THYROID GLAND; THYROID NEOPLASMS; WHOLE BODY IMAGING;

EID: 35348962477     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2006.0276     Document Type: Article

References (16)

1. Mazzaferri EL, Jhiang SM 1994 Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97:418-428.
2. Robbins RJ, Chon JT, Fleisher M, Larson SM, Turtle RM 2002 Is the serum thyroglobulin response to recombinant human thyrotropin sufficient, by itself, to monitor for residual thyroid carcinoma? J Clin Endocrinol Metab 87:3242-3247.
3. Ringel MD, Ladenson PW, Levine MA 1998 Molecular diagnosis of residual and recurrent thyroid cancer by amplification of thyroglobulin messenger ribonucleic acid in peripheral blood. J Clin Endocrinol Metab 83:4435-4442.
4. Simon D, Körber C, Krausch M, Segering J, Groth P, Görges R, Grünwald F, Müller-Gärtner HM, Schmutzler C, Köhrle J, Röher HD, Reiners C 2002 Clinical impact of retinoids in redifferentiation therapy of advanced thyroid cancer: final results of a pilot study. Eur J Nucl Med 29:775-782.
5. Coelho SM, Corbo R, Buescu A, Carvalho DP, Vaisman M 2004 Retinole acid in patients with radioiodine non-responsive thyroid carcinoma. J Endocrinol Invest 27:334-339.
6. Klopper JP, Hays WR, Sharma V, Baumbush MA, Hershman JM, Haugen BR 2004 Retinoid X receptor-gamma and peroxisome proliferator-actived receptor-gamma expression predicts thyroid carcinoma cells response to retinoid and thiazolidinedione treatment. Mol Cancer Ther 3:1011-1020.
7. Coelho SM, Corbo R, Breitenbach MMD, Carvalho J, Buescu A, Carvalho DP, Vaisman M 2003 Retinole acid (RA) receptor beta expression as a possible predictive factor of response to redifferentiation therapy in patients with metastatic thyroid cancer. Thyroid 13:730.
8. Pacini F, Malinao E, Castagna MG, Lippi F, Ceccarelli C, Agate L, Elisei R, Pinchera A 2002 Ablation of thyroid residues with 30 mCi (131)I: a comparison in thyroid cancer patients prepared with recombinant human TSH or thyroid hormone withdrawal. J Clin Endocrinol Metab 87:4063-4068.
9. Kamel N, Corapcioglu D, Sahin M, Gursoy A, Kucuk O, Aras G 2004 I-131 therapy for thyroglobulin positive patients without anatomical evidence of persistent disease. J Endocrinol Invest 27:949-953.
10. Pacini F, Lippi F, Formica N, Elisei R, Anelli S, Ceccarelli C 1987 Therapeutic doses of iodine-131 reveal undiagnosed metastases in thyroid cancer patients with detectable serum thyroglobulin levels. J Nucl Med 28:1888-1891.
11. Frasoldati A, Pesenti M, Gallo M, Caroggio A, Salvo D, Valcavi R 2003 Diagnosis of neck recurrences in patients with differentiated thyroid carcinoma. Cancer 97:91-96.
12. Torlontano M, Attard M, Crocetti U, Tumino S, Bruno R, Costante G, D'Azzo G, Meringolo D, Ferretti E, Sacco R, Arturi F, Filetti S 2004 Follow-up of low risk patients with papillary thyroid cancer: role of neck ultrasonography in detecting lymph node metastases. J Clin Endocrinol Metab 89:3402-3407.
13. Robbins RJ, Wan Q, Grewal RK, Reibke R, Gonen M, Strauss HM, Tuttle RM, Drucker W, Larson SM 2006 Real-time prognosis for metastatic thyroid carcinoma based on 2-[18F]fluoro-2-deoxy-D-glucose-positron emission tomography scanning. J Clin Endocrinol Metab 91:498-505.
14. Kurebayashi J, Tanaka K, Otsuki T, Moriya T, Kunisue H, Uno M, Sonoo H 2000 All-trans-retinoic acid modulates expression levels of thyroglobulin and cytokines in a human poorly differentiated papillary thyroid carcinoma cell line, KTC-1. J Clin Endocrinol Metab 85:2889-2896.
15. Schmutzler C, Winzer R, Maissner-Weigl J, Köhrle J 1997 Retinoic acid increases sodium/iodide symporter mRNA levels in human thyroid cancer cell lines and suppresses expression of function symporter in nontransformed FRTL-5 rat thyroid cells. Biochem Biophys Res Commun 240:832-838.
16. Schreck R, Schnieders F, Schmutzler C, Köhrle J 1994 Retinoids stimulate type I iodothyronine 5′-deiodinase activity in human follicular thyroid carcinoma cell lines. J Clin Endocrinol Metab 79:791-798.